Friday, April 8, 2011

Ringworm In People Of Color



identify the first patient

treated with stem cells

embryonic

21 year old who suffered a severe spinal cord injury after a car accident, received a revolutionary treatment.

by La Tercera - 07/04/2011
After the FDA last year approved the first treatment in humans with embryonic stem cells to cure people with paraplegia, the identity of the first patient to receive therapy had saved with total reserves. Until now.

This, as The Washington Post revealed that Timothy J. Atchison, a young American of 21 years, is the first patient to receive this revolutionary treatment, after being stranded product of an auto accident last September.

Atchinson According account, after the crash and to receive all emergency care at a medical center in Alabama (the town where he was studying nursing), was transferred to Shepherd Center in Atlanta, a place that specializes in spinal cord injury.

's where the medical team identified that Atchison was the ideal patient to receive the innovative treatment, therapy should be administered to a person who had been paralyzed from the chest to the bottom of body, and injection of embryonic stem cells in the wound area should be carried out between seven and 14 days after the injury occurs, among other requirements.

With a team of specially trained to treat (the laboratory Geron trained seven U.S. centers to implement the procedure), the patient received about 2 million stem cells into his spine, which, according to previous studies in laboratory mice, " become oligodendritos achieved, cells that produce myelin, a substance that covers the motor neurons and which enables the brain nerve impulses travel to the extremities and causing movement the body.

In research conducted by the University of California-Irvine in 2005, paralyzed mice were able to regain their mobility. The same is expected for this young man, who said in the interview with the U.S., which remains optimistic about the treatment, although so far experienced no major changes. "It's too early to talk about it," says Atchison.

0 comments:

Post a Comment